XML 44 R98.htm IDEA: XBRL DOCUMENT
v3.20.1

Goodwill - Details of and movement in goodwill (Details) - EUR (€) € in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2019 | Dec. 31, 2018
Goodwill |  |
Goodwill at beginning of the year | € 5,209,230 | € 4,590,498
Business Combination | 198,208 | 403,335
Disposals |  | (2,827)
Translation differences | 99,625 | 218,224
Goodwill at end of the year | 5,507,063 | 5,209,230
Grifols UK Ltd. (UK) |  |
Goodwill |  |
Goodwill at beginning of the year | 7,682 | 7,745
Translation differences | 425 | (63)
Goodwill at end of the year | 8,107 | 7,682
Grifols Italia S.p.A. (Italy) |  |
Goodwill |  |
Goodwill at beginning of the year | 6,118 | 6,118
Goodwill at end of the year | 6,118 | 6,118
Biomat USA, Inc. |  |
Goodwill |  |
Goodwill at beginning of the year | 255,114 | 205,254
Business Combination | (4,278) | 42,780
Disposals |  | (2,827)
Translation differences | 5,060 | 9,907
Goodwill at end of the year | 255,896 | 255,114
Grifols Australia Pty Ltd. (Australia) / Medion Diagnostics AG (Switzerland) |  |
Goodwill |  |
Goodwill at beginning of the year | 9,271 | 9,543
Translation differences | 201 | (272)
Goodwill at end of the year | 9,472 | 9,271
Grifols Therapeutics, Inc. (USA) |  |
Goodwill |  |
Goodwill at beginning of the year | 1,940,776 | 1,852,905
Translation differences | 38,902 | 87,871
Goodwill at end of the year | 1,979,678 | 1,940,776
Araclon Biotech, S.L. (Spain) |  |
Goodwill |  |
Goodwill at beginning of the year | 6,000 | 6,000
Goodwill at end of the year | 6,000 | 6,000
Progenika Biopharma, S.A. |  |
Goodwill |  |
Goodwill at beginning of the year | 40,516 | 40,516
Goodwill at end of the year | 40,516 | 40,516
Grifols Diagnostic (Novartis & Hologic) (USA, Spain and Hong Kong) |  |
Goodwill |  |
Goodwill at beginning of the year | 2,550,256 | 2,435,907
Translation differences | 50,694 | 114,349
Goodwill at end of the year | 2,600,950 | 2,550,256
Kiro Grifols S.L (formerly Kiro Robotics S.L) |  |
Goodwill |  |
Goodwill at beginning of the year | 24,376 | 26,510
Business Combination |  | (2,134)
Goodwill at end of the year | 24,376 | 24,376
Goetech, LLC. ("MedKeeper") |  |
Goodwill |  |
Goodwill at beginning of the year | 58,945 |
Business Combination |  | 55,321
Translation differences | 1,181 | 3,624
Goodwill at end of the year | 60,126 | 58,945
Haema, AG |  |
Goodwill |  |
Goodwill at beginning of the year | 171,134 |
Business Combination | 18,880 | 171,134
Goodwill at end of the year | 190,014 | 171,134
Biotest US Corporation |  |
Goodwill |  |
Goodwill at beginning of the year | 139,042 |
Business Combination | 10,943 | 136,234
Translation differences | 2,963 | 2,808
Goodwill at end of the year | 152,948 | € 139,042
Interstate Blood Bank, Inc. (USA) |  |
Goodwill |  |
Business Combination | 172,663 |
Translation differences | 199 |
Goodwill at end of the year | € 172,862 |

X
- Definition The amount of additional goodwill recognised due to a business combination. + References No definition available. + Details
Name: | grfs_RecognitionOfGoodwillFromBusinessCombination
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The decrease in goodwill due to classification as held for sale. [Refer: Goodwill; Disposal groups classified as held for sale [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B67 -Subparagraph d -Clause iv -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B67_d_iv&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_DecreaseThroughClassifiedAsHeldForSaleGoodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B67 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2019-01-01 -Paragraph 134 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2019-en-r&anchor=para_134_a&doctype=Standard -URIDate 2019-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2019-01-01 -Paragraph 135 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2019-en-r&anchor=para_135_a&doctype=Standard -URIDate 2019-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 54 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_54_c&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_Goodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The increase (decrease) in goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Goodwill] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B67 -Subparagraph d -Clause vi -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B67_d_vi&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_GrifolsUkLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_GrifolsItaliaS.p.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_BiomatUsaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_GrifolsAustraliaPtyLtdAndMedionDiagnosticsAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_GrifolsTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_AraclonBiotechSlMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_ProgenikaBiopharmaSaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_GrifolsDiagnosticNovartisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_KiroGrifolsS.lMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_GoetechLlc.AcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_HaemaAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_BiotestUsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_InterstateBloodBankIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |